POMA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 7.162
EU - Europa 4.576
AS - Asia 3.599
SA - Sud America 635
AF - Africa 128
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 16.107
Nazione #
US - Stati Uniti d'America 7.042
SG - Singapore 1.298
IT - Italia 1.175
RU - Federazione Russa 1.048
CN - Cina 882
BR - Brasile 524
FI - Finlandia 518
UA - Ucraina 382
HK - Hong Kong 378
DE - Germania 359
VN - Vietnam 348
PL - Polonia 213
IE - Irlanda 201
GB - Regno Unito 193
FR - Francia 173
JP - Giappone 135
IN - India 112
SE - Svezia 108
TR - Turchia 81
BD - Bangladesh 79
CA - Canada 52
KR - Corea 52
MX - Messico 43
AR - Argentina 40
IQ - Iraq 38
NL - Olanda 38
BE - Belgio 35
PK - Pakistan 29
ZA - Sudafrica 26
MY - Malesia 25
ES - Italia 24
CI - Costa d'Avorio 22
MA - Marocco 21
VE - Venezuela 21
AT - Austria 19
RO - Romania 18
UZ - Uzbekistan 17
EG - Egitto 16
IR - Iran 16
BG - Bulgaria 15
SA - Arabia Saudita 14
EC - Ecuador 13
CH - Svizzera 12
CL - Cile 12
ID - Indonesia 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
AZ - Azerbaigian 9
LT - Lituania 9
DZ - Algeria 8
PH - Filippine 8
HN - Honduras 7
KZ - Kazakistan 7
KE - Kenya 6
LB - Libano 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
BH - Bahrain 5
CO - Colombia 5
GR - Grecia 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
JO - Giordania 4
MT - Malta 4
NP - Nepal 4
PE - Perù 4
PS - Palestinian Territory 4
PY - Paraguay 4
TW - Taiwan 4
AU - Australia 3
ET - Etiopia 3
EU - Europa 3
GH - Ghana 3
GT - Guatemala 3
LY - Libia 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
JM - Giamaica 2
KG - Kirghizistan 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
TH - Thailandia 2
AM - Armenia 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 16.100
Città #
Ashburn 881
Singapore 866
Fairfield 699
Chandler 404
Houston 398
Woodbridge 373
Hong Kong 365
San Jose 361
Palermo 344
Ann Arbor 331
Wilmington 297
Seattle 257
Cambridge 222
Jacksonville 207
Dublin 195
Zgierz 191
Moscow 172
Santa Clara 156
Beijing 152
Des Moines 141
Medford 136
Tokyo 130
Los Angeles 122
Ho Chi Minh City 121
Council Bluffs 119
New York 119
Frankfurt am Main 107
Dallas 90
Nanjing 89
Lauterbourg 85
Princeton 85
Boardman 80
Hanoi 76
The Dalles 76
Helsinki 73
Hefei 66
Altamura 62
Tulsa 55
San Diego 51
São Paulo 50
Lawrence 48
Buffalo 45
Dearborn 43
Rome 36
Milan 35
Izmir 33
Brussels 32
Venice 32
Nanchang 28
Shenyang 28
Hebei 27
Ludwigshafen am Rhein 27
London 26
Atlanta 25
Bremen 25
Chicago 24
Abidjan 22
Changsha 22
Brooklyn 21
Columbus 20
Rio de Janeiro 20
Shanghai 20
Jinan 19
Munich 19
Denver 18
Falls Church 18
Kuala Lumpur 18
Messina 17
Nuremberg 17
Orem 17
Phoenix 17
Montreal 16
Belo Horizonte 15
Hangzhou 15
Verona 15
Baghdad 14
Brasília 14
Jiaxing 14
Johannesburg 14
Ningbo 14
San Paolo di Civitate 14
Seongnam 14
Warsaw 14
Amsterdam 13
Catania 13
Kumar 13
Tashkent 13
Zhengzhou 13
Chennai 12
Da Nang 12
Guangzhou 12
Naples 12
Saint Petersburg 12
Sofia 12
Stockholm 12
Tianjin 12
Auburn Hills 11
Manchester 11
Paris 11
Poplar 11
Totale 9.981
Nome #
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 314
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 291
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 277
Targeting Multiple Myeloma with natural polyphenols 277
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 274
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 264
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 260
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 251
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 247
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 245
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 241
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 241
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 241
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 240
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 232
Expression of the IAPs in multidrug resistant tumor cells 225
Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems 225
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 224
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 211
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 208
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 208
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 205
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 204
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 202
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 202
Co-loaded cardanol/triazole-halloysite system: characterization of the supramolecular complex and evaluation of its antiproliferative activity 197
Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications 194
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 194
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 194
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 192
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 191
Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives 191
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 184
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 184
Unusual high dose of tacrolimus in liver transplant patient, a case report. 183
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 181
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 180
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 180
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 176
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 176
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 175
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 174
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 172
Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilisation and caspase-3 activation 170
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 168
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 167
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 165
null 164
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 163
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 161
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 160
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 160
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 159
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 157
Caratterizzazione e valutazione dell’attività anti proliferativa di nuovi sistemi per il drug carrier Allosite-sali triazolici/cardanolo 153
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 153
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 153
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 152
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 151
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 151
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 150
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 146
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 145
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 145
SYNTHESIS AND CHARACTERIZATION OF POSITIVELY CHARGED FUNCTIONALIZED HALLOYSITE/CURCUMIN SYSTEMS AND EVALUATION OF THEIR ANTICANCER ACTIVITY 140
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 139
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 139
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 139
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 139
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 136
NF-κB is a potential pharmacological target in triple negative breast cancers. 135
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 131
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 131
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 129
Antitumor effects of curcumin and of its combinations with cisplatin or doxorubicin on human hepatic cancer cells: Possible relationship to NF-kB activation and IAP gene expression 127
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 123
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 122
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 121
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 117
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 115
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 115
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 114
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 114
Inhibitor of apoptosis proteins (IAPs) as new possible therapeutic targets in hepatocellular cancer 112
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 110
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 109
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 107
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 105
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 103
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 103
Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance 102
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 100
A Curcumin-BODIPY Dyad and Its Silica Hybrid as NIR Bioimaging Probes 98
Plant polyphenols as privileged multi-target compounds for chemo- and immuno-sensitization 96
NF-kB and Disease 92
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 87
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 71
null 67
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug Delivery 51
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 31
Totale 16.590
Categoria #
all - tutte 53.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 0 0 0 0 0 0 0 0 0 0 146 107
2021/20221.172 50 236 32 21 57 37 72 41 117 197 77 235
2022/20231.335 140 209 22 155 161 217 107 84 147 14 65 14
2023/2024692 50 98 50 27 38 137 48 48 14 36 40 106
2024/20252.152 43 185 111 193 124 82 196 141 189 226 238 424
2025/20266.098 426 204 381 511 569 959 895 631 430 839 253 0
Totale 16.590